Regeneron Shares Rise 11.5% After Third-Quarter Revenue and EPS Increase
Regeneron reported third-quarter 2026 revenue of $5.1 billion, up 36%, and non-GAAP diluted EPS of $20.07, up 70%.
What happened? Shares of biotech company Regeneron NASDAQ:REGNjumped 11.5% in the afternoon session after the company reported a 36% increase in third-quarter 2026 revenue to $5.1 billion, alongside a 70% rise in non-GAAP diluted earnings per share to $20.07.According to a company press release, Re…